IS4924A - Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders - Google Patents

Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Info

Publication number
IS4924A
IS4924A IS4924A IS4924A IS4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A
Authority
IS
Iceland
Prior art keywords
treatment
acetic acid
acid derivatives
thrombotic disorders
piperidine acetic
Prior art date
Application number
IS4924A
Other languages
Icelandic (is)
Inventor
George Allen David
David Eldred Colin
Leonard Mitchell William
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4924A publication Critical patent/IS4924A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4924A 1996-06-21 1998-12-15 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders IS4924A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
IS4924A true IS4924A (en) 1998-12-15

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4924A IS4924A (en) 1996-06-21 1998-12-15 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Country Status (17)

Country Link
EP (1) EP0912555A1 (en)
JP (1) JP2000512648A (en)
KR (1) KR20000022041A (en)
AP (1) AP9801417A0 (en)
AR (1) AR008245A1 (en)
AU (1) AU3261197A (en)
BR (1) BR9709930A (en)
CA (1) CA2258753A1 (en)
CZ (1) CZ424698A3 (en)
EA (1) EA199801015A1 (en)
ID (1) ID17052A (en)
IL (1) IL127464A0 (en)
IS (1) IS4924A (en)
NO (1) NO985974L (en)
PL (1) PL330797A1 (en)
TR (1) TR199802665T2 (en)
WO (1) WO1997049699A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7064215B2 (en) 2001-07-03 2006-06-20 Chiron Corporation Indazole benzimidazole compounds
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
EP1592683A2 (en) * 2003-02-14 2005-11-09 Wyeth Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
JP2009532471A (en) 2006-04-05 2009-09-10 ワイス Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
BRPI0806542A2 (en) 2007-01-10 2014-04-22 Hoffmann La Roche SULFONAMIDE DERIVATIVES AS CHEMASE INHIBITORS
CN113655155A (en) * 2021-07-28 2021-11-16 任贤金 Method for measuring SPH3127 related substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
TW221996B (en) * 1991-11-14 1994-04-01 Glaxo Group Ltd
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NO985974L (en) 1999-02-17
PL330797A1 (en) 1999-06-07
AP9801417A0 (en) 1998-12-31
TR199802665T2 (en) 1999-03-22
WO1997049699A1 (en) 1997-12-31
EP0912555A1 (en) 1999-05-06
JP2000512648A (en) 2000-09-26
AU3261197A (en) 1998-01-14
CA2258753A1 (en) 1997-12-31
IL127464A0 (en) 1999-10-28
EA199801015A1 (en) 1999-08-26
AR008245A1 (en) 1999-12-29
KR20000022041A (en) 2000-04-25
BR9709930A (en) 1999-08-10
ID17052A (en) 1997-12-04
CZ424698A3 (en) 1999-05-12
NO985974D0 (en) 1998-12-18

Similar Documents

Publication Publication Date Title
NO990700D0 (en) Propionic acid derivatives and their use
NO2008002I1 (en) Protioconazole and its salts
NO20001754D0 (en) Prostaglandin agonists and their use in the treatment of bone disorders
NO972972L (en) Compositions for the treatment of dermatological disorders and methods for their use
DE69813570D1 (en) 5-ALKYL-2-ARYLAMINOPHENYL ACETIC ACID AND DERIVATIVE
NO953991D0 (en) Piezotype ultrasomic and electrosurgical handpiece
NO994778L (en) Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome
IS4481A (en) Dihydropyramidine and their use
DK0741594T3 (en) Photothermal therapeutic device and method
FI953838L (en) Imidazopyridines and their use in the treatment of gastrointestinal diseases
EE05067B1 (en) Aminopropphosphinic acids and their use in medicine
FI940216A0 (en) Quinolone and naphthyridonecarboxylic acid derivatives
NO975439D0 (en) Ketone derivatives and their medical use
DK0928333T3 (en) Metabolically optimized lactic acid bacteria and their use
IS5021A (en) Use of combinations of H +, K + -ATPase inhibitors and glucocorticosteroids in the treatment of nasal pagers
NO950936D0 (en) 5-vinyl and 5-ethinylquinolone and naphthyridone carboxylic acids
IS4924A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
NO20012738D0 (en) Therapeutic products and their use
FI971193A7 (en) Quinoxaline derivatives useful in therapy
FI954138L (en) Hydroxymethylfurazancarboxylic acid derivatives and their use in the treatment of cardiovascular diseases
FI954680A7 (en) Quinolone and naphthyridonecarboxylic acid derivatives
IS4140A (en) Use of ferrozene and / or ferrozene derivatives
NO981002D0 (en) Carboxylic acid derivatives, their preparation and use
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory